OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
462857

SK Kaken Co Ltd

Commodity ChemicalsVerified

SK Kaken maintains a strong liquidity position, with a current ratio of 6.04 and cash and equivalents amounting to ¥108.79 billion, which significantly exceeds its total liabilities of ¥27.59 billion. The company's debt-to-equity ratio is 0.02, indicating a conservative capital structure with minimal reliance on debt financing. This liquidity profile supports operational flexibility and resilience against short-term financial shocks. Profitability metrics show that SK Kaken's return on equity (ROE) is 6.56%, and its return on assets (ROA) is 5.61%. These figures are in line with the industry's preferred metrics for profitability, suggesting that the company is effectively utilizing its equity and asset base to generate returns. The operating margin, derived from operating income of ¥12.44 billion on revenue of ¥106.14 billion, is 11.72%, which is a strong indicator of cost control and pricing power. Geographically, SK Kaken's revenue is primarily concentrated in Japan, with no disclosed international segments in the provided data. This concentration may expose the company to domestic economic fluctuations and regulatory changes, but it also allows for focused operational management and customer relationships. Looking ahead, SK Kaken is projected to maintain a stable growth trajectory, with no significant revenue changes expected in the next fiscal year. The company's capital expenditure of ¥1.37 billion in the latest period suggests a measured approach to investment, which aligns with its conservative financial strategy. This approach may limit rapid growth but ensures financial stability and reduces the risk of overleveraging. Risk factors for SK Kaken include the potential for regulatory changes in the chemical industry and the volatility of raw material prices, which can impact gross margins. However, the company's strong liquidity and low debt levels mitigate the risk of financial distress. There is no immediate dilution potential, as the number of shares outstanding has not changed between basic and diluted figures, and no recent equity issuance or shelf registration events have been reported. Recent events, as reflected in the latest financial filings, show consistent performance with no material deviations from previous periods. The company's operating cash flow of ¥8.28 billion and free cash flow of ¥8.1 billion indicate strong cash generation capabilities, which support dividend sustainability and reinvestment opportunities.

30-day price · 4628(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySK Kaken Co Ltd
Ticker4628.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. SK Kaken Co Ltd is a Japanese chemical company that produces and sells a range of chemical products, primarily serving industrial and manufacturing sectors.

Classification. SK Kaken is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

SK Kaken maintains a strong liquidity position, with a current ratio of 6.04 and cash and equivalents amounting to ¥108.79 billion, which significantly exceeds its total liabilities of ¥27.59 billion. The company's debt-to-equity ratio is 0.02, indicating a conservative capital structure with minimal reliance on debt financing. This liquidity profile supports operational flexibility and resilience against short-term financial shocks. Profitability metrics show that SK Kaken's return on equity (ROE) is 6.56%, and its return on assets (ROA) is 5.61%. These figures are in line with the industry's preferred metrics for profitability, suggesting that the company is effectively utilizing its equity and asset base to generate returns. The operating margin, derived from operating income of ¥12.44 billion on revenue of ¥106.14 billion, is 11.72%, which is a strong indicator of cost control and pricing power. Geographically, SK Kaken's revenue is primarily concentrated in Japan, with no disclosed international segments in the provided data. This concentration may expose the company to domestic economic fluctuations and regulatory changes, but it also allows for focused operational management and customer relationships. Looking ahead, SK Kaken is projected to maintain a stable growth trajectory, with no significant revenue changes expected in the next fiscal year. The company's capital expenditure of ¥1.37 billion in the latest period suggests a measured approach to investment, which aligns with its conservative financial strategy. This approach may limit rapid growth but ensures financial stability and reduces the risk of overleveraging. Risk factors for SK Kaken include the potential for regulatory changes in the chemical industry and the volatility of raw material prices, which can impact gross margins. However, the company's strong liquidity and low debt levels mitigate the risk of financial distress. There is no immediate dilution potential, as the number of shares outstanding has not changed between basic and diluted figures, and no recent equity issuance or shelf registration events have been reported. Recent events, as reflected in the latest financial filings, show consistent performance with no material deviations from previous periods. The company's operating cash flow of ¥8.28 billion and free cash flow of ¥8.1 billion indicate strong cash generation capabilities, which support dividend sustainability and reinvestment opportunities.
Key takeaways
  • SK Kaken has a strong liquidity position with a current ratio of 6.04 and significant cash reserves.
  • The company's ROE of 6.56% and ROA of 5.61% indicate efficient use of capital and assets.
  • Revenue is concentrated in Japan, which may limit diversification but allows for focused operations.
  • The company maintains a conservative capital structure with minimal debt and no immediate dilution risks.
  • SK Kaken's stable growth trajectory and strong cash flow generation support financial resilience.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$106.14B
Gross profit$32.27B
Operating income$12.44B
Net income$10.73B
R&D
SG&A
D&A
SBC
Operating cash flow$8.28B
CapEx-$1.37B
Free cash flow$8.10B
Total assets$191.11B
Total liabilities$27.59B
Total equity$163.52B
Cash & equivalents$108.79B
Long-term debt$3.00B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$163.52B
Net cash$105.79B
Current ratio6.0
Debt/Equity0.0
ROA5.6%
ROE6.6%
Cash conversion77.0%
CapEx/Revenue-1.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4628Activity
Op margin11.7%0.4% medp25 -8.0% · p75 16.0%above median
Net margin10.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin30.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity2.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS795.55 JPY
Last actual revenue106,142,000,000 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 22:02 UTCJob: 3451632f